Abstract We have recently demonstrated that rat cytomegalovirus (RCMV) infection induces an early inflammatory response in the adventitia (perivasculitis) and in the subendothelial space (endothelialitis) as well as doubles smooth muscle cell (SMC) proliferation and intimal thickening of rat aortic allografts performed from the DA (AG-B4, RT1 1 ) to the WF (AG-B2, RT1 Y ) strain. In this study, the impact of RCMV infection on the structure of inflammation in the allograft adventitia and on the expression of SMC growth factors in the allograft vascular wall was investigated. The recipient rats were inoculated with 10 5 plaque-forming U of RCMV Maastricht strain or left noninfected and used as controls. The allografts were removed at 7 days and 1 and 3 months after transplantation and processed for morphometry and immunohistochemistry. RNA was isolated for reverse transcriptase polymerase chain reaction (RT-PCR). RCMV infection was associated with significantly upregulated presence (P<.05) of T helper (W3/25), T cytotoxic (OX8), and natural killer (3.2.3) cells in the allograft adventitia 7 days after transplantation but not thereafter. More monocyte/macrophages (OX42) were also present in RCMV-infected allografts, but the difference was not significant. Concomitantly, RCMV infection significantly enhanced (P<.05) the expression of major histocompatibility complex class II (OX6) and almost doubled (P=NS) the expression of interleukin-2R (CD25), intercellular adhesion molecule-1 (CD54;1A29), and lymphocyte function-associ-C ardiac allograft arteriosclerosis, ie, chronic rejection, has emerged as a major factor limiting the long-term survival of heart transplant recipients.
Abstract We have recently demonstrated that rat cytomegalovirus (RCMV) infection induces an early inflammatory response in the adventitia (perivasculitis) and in the subendothelial space (endothelialitis) as well as doubles smooth muscle cell (SMC) proliferation and intimal thickening of rat aortic allografts performed from the DA (AG-B4, RT1 1 ) to the WF (AG-B2, RT1 Y ) strain. In this study, the impact of RCMV infection on the structure of inflammation in the allograft adventitia and on the expression of SMC growth factors in the allograft vascular wall was investigated. The recipient rats were inoculated with 10 5 plaque-forming U of RCMV Maastricht strain or left noninfected and used as controls. The allografts were removed at 7 days and 1 and 3 months after transplantation and processed for morphometry and immunohistochemistry. RNA was isolated for reverse transcriptase polymerase chain reaction (RT-PCR). RCMV infection was associated with significantly upregulated presence (P<.05) of T helper (W3/25), T cytotoxic (OX8), and natural killer (3.2.3) cells in the allograft adventitia 7 days after transplantation but not thereafter. More monocyte/macrophages (OX42) were also present in RCMV-infected allografts, but the difference was not significant. Concomitantly, RCMV infection significantly enhanced (P<.05) the expression of major histocompatibility complex class II (OX6) and almost doubled (P=NS) the expression of interleukin-2R (CD25), intercellular adhesion molecule-1 (CD54;1A29), and lymphocyte function-associ-C ardiac allograft arteriosclerosis, ie, chronic rejection, has emerged as a major factor limiting the long-term survival of heart transplant recipients. 1 In angiograms, accelerated arteriosclerosis is characterized by diffuse concentric narrowing of the coronary vessels. 2 Microscopically, the basic underlying lesion is diffuse, concentric intimal thickening, mainly consisting of proliferating smooth muscle cells (SMCs) and macrophages. In addition, intramural and perivas-ated antigen-1 a-chain (CDlla; WT.l) in the adventitial inflammatory infiltrate. RCMV infection was linked with an early, prominent expression of both PDGF-BB mRNA at 7 days (P<.05) and at 1 month (P<.025) and of transforming growth factor-/3, mRNA at 7 days (P<.025) and at 1 month (P<.025) after transplantation. A less-prominent mRNA upregulation of acidic fibroblast growth factor (P<.05) was associated with RCMV infection at 7 days and at 1 month, as well as of epidermal growth factor at 1 month after transplantation, when compared with noninfected allografts, although the mRNA expression in both groups was below the levels of nontransplanted DA aortas. RCMV infection almost doubled basic fibroblast growth factor mRNA expression (P=NS) in the allograft vascular wall at 7 days and at 1 month. RCMV infection had no additional impact on insulin-like growth factor-1 mRNA expression when compared with noninfected allografts. Our results suggest that RCMV infection-induced early inflammatory response in the vascular wall is linked with an early activation of the inflammatory cells and enhanced mRNA expression of PDGF-BB and transforming growth factor-/3,. We suggest that these biochemical responses may play a role in the generation of RCMV-enhanced allograft arteriosclerosis. Clinical studies have revealed the association of cytomegalovirus (CMV) 1 infection and cardiac allograft arteriosclerosis. 46 We have recently demonstrated that CMV infection associated with acute alloimmune response induces an early, prominent inflammatory response in the allograft adventitia (perivasculitis) and in the intima (endothelialitis) as well as doubles SMC proliferation and intimal thickening in rat aortic allografts. 78 The immunologic and molecular mechanisms involved in allograft arteriosclerosis (chronic rejection) are virtually unknown. Studies in aortic allografts demonstrate that, during the induction of allograft arteriosclerosis, in the absence of CMV infection, several cytokines (including interleukin-1 [IL-1] and interferon--y [IFN-y]) and growth factors (including insulin-like growth factor-1 [IGF-1], epidermal growth factor [EGF] , and platelet-derived growth factor [PDGF]) are prominently expressed both on the peptide and mRNA levels in the vascular wall. 9 ' 10 The levels of eicosanoids, with the exception of thromboxane B 2 , are less altered.
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In this study we describe the structure of rat CMV (RCMV) infection-associated inflammatory and immunologic responses in the allograft adventitia. Furthermore, we demonstrate that RCMV infection-induced inflammatory and immunologic responses are linked with an enhanced mRNA expression of PDGF-BB and transforming growth factor (TGF)-/3, in the allograft vascular wall.
Methods Rats
Inbred DA (AG-B4, RT1') and WF (AG-B2, RT1") rat strains were used as donors and recipients, respectively. The rats were purchased from the Zentralinstitut fur Versuchstierzucht (Hannover, FRG). They were 2 to 3 months of age and weighed 200 to 300 g. The rats were fed with regular rat food (altromin, Standard Diet, Chr. Petersen A/S) and tap water ad libitum. All animals were maintained on a 12-hour light/dark cycle. The noninfected control rats were kept in separate colonies with otherwise similar diet and conditions. All animals received humane care in compliance with 
Aortic Allografts
The strain combination of DA to WF was used for allogeneic transplantation. An ~3-cm-long segment of descending DA rat thoracic aorta was removed, thoroughly perfused with phosphate-buffered saline (PBS), and used as transplant." End-to-end anastomosis was performed using 9-0 continuous nylon suture. The graft was transplanted into heterotopic position below renal arteries and above bifurcation, forming a loop in the recipient abdominal cavity. Total ischemic time varied from 45 minutes to 60 minutes, during which time the graft was kept in an ice bath at +4°C for 15 minutes. The experimental animals were anesthetized with chloral hydrate 240 mg/kg IP and were given 0.25 mg/kg buprenorphine SC (Temgesic; Reckitt & Colman) for postoperative pain relief. In this study, the grafts were removed at 7 days and at 1 month and 3 months after transplantation and processed for iraraunohistochemistry and reverse transcriptase-polymerase chain reaction (RT-PCR).
Rat Cytomegalovirus Infection in Allograft Recipients
RCMV infection in the allograft recipients was established by inoculating rats in the lower left abdomen with 10 5 plaqueforming U (PFU) IP of the Maastricht strain RCMV 1 day after transplantation.
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Propagation of Rat Cytomegalovirus
The virus was originally isolated by Bruggeman et al from wild rats. 12 The virus pools used for in vivo infection consisted of RCMV supernatant derived from fibroblast cell culture. RCMV Maastricht strain 7 ' 1214 was propagated by infecting rat embryo fibroblasts, prepared from 17-day-old DA rat embryos. The fibroblasts were cultured in flasks containing modified Eagle's minimum essential medium (MEM; Flow Laboratories) supplemented with 200 mmol/L L-glutamine (Northumbria Biologicals LTD), 10 000 IU/mL penicillin/1000 Mg/mL streptomycin solution (GIBCO Ltd), and 10% fetal calf serum (Sera-Lab) at +37°C in a 5% CO 2 incubator. When rat embryo fibroblast monolayers were confluent, they were infected with an appropriate amount of RCMV according to standard viral culture techniques 15 and maintained in culture media (as above) supplemented with 2% fetal calf serum (Sera-Lab). After 5 to 7 days, when cytopathic effect was observed in at least 95% of the cells, the cells were detached from the bottom of the flask by tapping and centrifuged at 1200 rpm for 5 minutes to the bottom of the tube. The overlaying supernatant containing free RCMV was collected and immediately stored at -70°C until used.
Quantitation of Infectious RCMV
Quantitation of infectious RCMV was done from the frozen virus stock by plaque assays as described by Wentworth and French. 16 Confluent DA rat embryo fibroblast monolayers were washed with Hanks' balanced salt solution (lx) (GIBCO), infected with appropriate virus dilution, and incubated at +37°C in a 5% CO 2 incubator for 60 minutes. After incubation, the infected cells were overlaid with 1 mL Eagle's basal medium (GIBCO) supplemented with 200 mmol/L L-glutamine (Northumbria Biologicals LTD), 10 000 IU/mL penicillin/1000 jig/mL streptomycin solution (GIBCO), and 5% fetal calf serum (Sera-Lab) with a final concentration of 0.25% agarose (Sigma). After the incubation of 7 days, the cells were fixed with 10% formalin overnight. The solid base layer was removed, and the cell monolayers were stained with 1% aqueous crystal violet (Merck), and the plaques were counted by light microscopy.
Scoring of Intimal Cells
A segment of graft was fixed in 10% buffered formalin, embedded in paraffin, and examined histologicalh/ after being sectioned and stained with Mayer's hematoxylin-eosin. Cross sections were prepared for evaluation, and the number of intimal SMCs and intimal mononuclear inflammatory cells was quantified on cytological criteria according to standard morphometric principles 17 and are expressed as point score units (PSU), ie, in mean number of points falling over a given anatomic area using straight, cross-sectional lines, and a 0.02-mm grid.
Immunohistochemistry
Immediately after graft removal, a piece of allograft was cut in optimal cutting temperature embedding (Tissue-Tek), snapfrozen in liquid nitrogen, and stored at -7CPC. Frozen sections were air-dried onto poly-D-lysine-coated slides, fixed in acetone at -20°C for 20 minutes, and stored at -20°C until stained. Before immunostaining, the slides were refixed with chloroform for 30 minutes to remove unspecific background staining and air-dried. Cross sections 3 to 4 /im thick of aortic allografts were stained with three-layer indirect immunoperoxidase technique, using mouse monoclonal antibodies (MAbs) to rat antigens. 18 Primary antibodies (see below) were used at appropriate dilutions (usually 1:100; MHC class II 1:200) in tris(hydroxymethyl)amino methane (TRIS) with 1% BSA. After a 30-minute incubation at room temperature, the sections were washed in TRIS buffer and incubated for 30 minutes with peroxidase-conjugated rabbit anti-mouse Ig (P161; Dako-immunoglobulins A/S). After the washing in TRIS, the sections were incubated with goat anti-rabbit Ig (L43007; Caltag Laboratory). The reaction was revealed by chromogen 3-amino-9-ethylcarbazole containing hydrogen peroxidase. The specimens were counterstained with hematoxylin, and coverslips were aquamounted (Aquamount; BDH Ltd).
To determine the leukocyte subsets of the inflammatory infiltrate, the following mouse antibodies to rat antigens were used: (1) W3/25 (Sera-Lab), a mouse IgG, MAb to rat T helper cells (CD 4 equivalent); (2) OX8 (Sera-Lab), a mouse IgG, MAb to rat T cells (nonhelper subset; Lyt2/Lyt3, CD8 equivalent); (3) 0X42 (Sera-Lab), a mouse IgG^ MAb to rat macrophages (160, 103, 96 kd polypeptide); and (4) To determine the immune activation of infiltrating leukocytes, the following MAbs were applied: (1) IL-2R, a MAb to rat IL-2 receptor (a generous gift from Dr J. Kupiec-Weglinski, Harvard Medical School); (2) OX6 (Sera-Lab), a mouse IgG, MAb to rat MHC class II common determinant; (3) 1A29 (Seikagaku Corp), a mouse IgG, MAb to rat intercellular adhesion molecule-1 (ICAM-1); CD54; and (4) WT.l (Seikagaku Corp), a mouse IgG^ MAb to rat lymphocyte functionassociated antigen-1 (LFA-1) a-chain; CDlla.
Immunohistochemical Quantitation
The immunohistochemical analysis was done in blind review by two observers. Positive staining for IL-2R was quantified as the number of positive cells per the cross section of the allograft adventitia. The expression of other molecules was scored semiquantitatively from 0 to 5 as follows: 0, no positive staining; 1, few cells with faint positive staining; 2, weak intensity of multifocal positive staining; 3, moderate intensity of multifocal positive staining; 4, diffuse intense positive staining; 5, very diffuse intense positive staining. Data are expressed as mean±SEM.
Total RNA Isolation
Immediately after graft removal, a piece of graft was stored in liquid nitrogen for RNA isolation. Total RNA was extracted from aortic transplants using guanidine-isothiocyanate preparation." Briefly, frozen tissues were mixed with 3 mL GIT buffer (4 mol/L guanidine isothiocyanate), and homogenized with an Ultra-Turrax homogenizer (Janke & Kunkel). Two milliliters 5.7 mol/L CsCl buffer was put into polyallomer ultracentrifuge tubes (Beckman Instruments), and the guanidine-lysed samples were added on top. The samples were centrifuged at 32 000 rpm for SW 50.1 at +20°C for 21 hours. After centrifugation, the supernatant was removed, and RNA was resuspended with TES buffer (10 mmol/L TRIS, pH 7.4, 5 mmol/L EDTA, pH 7.4,1% sodium dodecyl sulfate) for 2 to 3 hours in an ice bath. The resuspension was put into microfuge tubes, and the same volume of phenol was added. The samples were mixed and spun down to separate phases. The upper phase was removed to a new tube, and phenol purification was repeated twice. After that, phenol-chloroform(l:l) and, in the last step, only chloroform was added to samples to yield purified RNA. Aqueous RNA was precipitated using 3 mol/L sodium acetate (pH 5.2) and 2.5 x frozen ethanol. RNA concentrations were measured spectrophotometrically.
RT-PCR
One microgram of RNA was reverse-transcribed to cDNA using commercial Perkin Elmer Cetus Protocol. One microgram from the RT reaction was taken for PCR, 20 which was performed in PCR buffer (500 mmol/L Tris, pH 8.8, 15 mmol/L MgCl 2 , 150 mmol/L (NH,)SO 4 , 0.1% gelatin, 1% Triton X-100) using 0.2 mmol/L of each nucleotide, 1 ^tmol/L of both primers, and 2.5 U thermus Aquaticus {Taq) DNA polymerase. The samples were amplified 25 to 28 cycles each, denaturated (1 minute at +94°C), annealed (1 minute at +57°C), and extented (2 minutes at +72°C). As a control, PCR was also made using glyceraldehyde-3-phosphate dehydrogenase (GAPDH) primers. The samples were electrophoresed in agarose gel and Southern-blotted. Radiolabeled oligo probes were used to detect the PCR products. The intensity of hybridization signals was measured by densitometry (Electrophoresis Data Center), and the results are expressed as the ratio of growth factor mRNA and GAPDH mRNA±SEM. The primers and probes were prepared at the Molecular/ Cancer Biology Laboratory, Department of Pathology, University of Helsinki.
The following rat sequences were used as primers: (1) IGF-1, 5'-GAC GCT CTT CAG TTC GTG TGT GGA-3', 5'-GCA GGT GTT CCG ATG TTT TGC AGG-3'; (2) EGF, 5-TGA GAT GGG CAC AGA GCA AAG CTG-3', 5'-GGA AGG ACA CAG CTT ACA CAC GTG-3'; (3) BB-isomer of PDGF, 5'-GAA GCC AGT CTT CAA GAA GGC CAC-3', 5'-AAC GGT CAC CCG AGT TTG AGG TGT-3'; (4) TGF-ft, 5'-ACG TCA GAC ATT CGG GAA GCA GTG-3', 5'-GCA AGG ACC TTG CTG TAC TGT GTG-3'; (5) acidic fibroblast growth factor (aFGF), 5'-ACA GGA GCG ACC AGC ACA TTC AG-3', 5-GAG A AA CAA GAT GGC TTT CTG GCC-3'; (6) basic fibroblast growth factor (bFGF), 5-ACT TCA AGG ATC CCA AGC GGC TCT-3', 5'-TGC CCA GTT CGT TTC AGT GCC ACA-3'; and (7) glyceraldehyde-3-phosphate dehydrogenase (GAPDH), 5'-GTC TTC ACC ACC ATG GAG AAG GCT-3', 5-TGT AGC CCA GGA TGC CCT TTA GTG-3'.
The following sequences were used as probes: (1) The rat cDNA sequence of TGF-ft was obtained from the EMBL (accession number X52498 for TGF-/3,), and all other sequences were obtained from the GenBank (accession numbers are M15480 for IGF-1, M63585 for EGF, Z14117 for PDGF-BB, M22427 for bFGF, and M17701 for GAPDH). There is no cDNA sequence available for aFGF, and the primer and probe sequences used were prepared combining sequences of mouse (M30641), bovine (X13221), and human (S90026).
Statistics
Data are expressed as mean±SEM; in the case of nontransplanted DA rat aortas, as mean±SD. A nonparametric test was chosen due to small sample sizes and inability to determine if the samples were normally distributed. The nonparametric Mann-Whitney U test (z for corrected ties) was used to evaluate the significances. P values <.O5 were regarded as statistically significant: 21 
'
Results
RCMV Infection in Allograft Recipients
The allograft recipients were exposed to 10 5 PFU IP RCMV 1 day after heterotopic aortic transplantation or left noninfected and used as controls. As described earlier, 7 an acute infection with systemic virus dissemination occurs during 7 to 14 days. Thereafter, the infection progresses to a chronic phase, and RCMV can be recovered only from the salivary glands of the rat. By approximately 4 months after infection, infectious RCMV is no longer present in any organ or tissue, and the rat is presumed to be latently infected.
RCMV-Enhanced Allograft Arteriosclerosis
Nonimmunosuppressed rat aortic allografts from the DA to the WF rat strain develop vascular wall changes that are histologically almost indistinguishable from those observed during cardiac allograft arteriosclerosis in humans. 10 We have recently demonstrated that RCMV infection significantly enhances the generation of rat aortic allograft arteriosclerosis. First, the infection is associated with an early, prominent inflammatory 
Effect of RCMV Infection on Phenotypic Distribution of Leukocyte Subsets in the Allograft Adventitia
To investigate the effect of RCMV infection on the phenotypic distribution of leukocyte subsets in the allograft adventitia, aortic frozen cross sections were stained with three-layer immunoperoxidase technique using mouse MAbs to rat T helper (W3/25), T cytototoxic (OX8), NK (3.2.3) cells, and monocyte/macrophages (OX42). The results are depicted in Fig 2, and representative illustrations are shown in Fig 3. Frozen cross sections of nontransplanted DA aortas did not contain any T helper, T cytotoxic, NK cells, or cells of the monocyte/macrophage lineage (not shown). In noninfected allografts, T helper cells and monocyte/macrophages were present in small numbers and reached a clear peak 1 month after transplantation. Few T cytotoxic and NK cells were also found (Fig 2) . RCMV infection significantly enhanced (P<.05) T helper, T cytotoxic, and NK cells in the adventitial inflammatory infiltrate 7 days after transplantation when compared with noninfected allografts. RCMV infection also elevated the presence of monocyte/macrophages, but the difference was not statistically significant. Later, the differences disappeared (Fig 2) .
Effect of RCMV Infection on the Level of Immune Activation in the Allograft Adventitia
To investigate the effect of RCMV infection on immune activation of adventitial inflammatory infiltrate, frozen aortic cross sections were stained with three-layer indirect immunoperoxidase technique using mouse MAbs to rat IL-2 receptor (CD25), MHC class II (OX6), ICAM-1 (CD54; 1A29), and LFA-1 a-chain (CDlla; WT.l). The results are given in the Table. In the adventitia of nontransplanted DA aortas there was no expression of IL-2 receptor, ICAM-1, or LFA-1 (Table) . RCMV infection induced an early activation on the adventitial inflammatory cells, detectable already 7 days after transplantation with a significant upregulation (P<.05) of MHC class II molecule and elevations (P=NS) of IL-2 receptor, ICAM-1, and LFA-1 a-chain.
Effect of RCMV Infection on Growth Factor mRNA Expression in the Allograft Vascular Wall
To investigate the effect of RCMV infection on SMC growth factor mRNA expression in the allograft vascular wall, total RNA was extracted and used for RT-PCR. The results are given as the ratio of intensity of growth factor and GAPDH mRNA±SEM and are depicted in Fig 4. Representative illustrations of blots are shown in Fig 5. IGF-1. In nontransplanted DA aortas, the level of mRNA for IGF-1 was 250±68. In noninfected allografts, IGF-1 mRNA expression reached a peak of 4308±1031 at 7 days, thereafter declined to, 2079± 642 at 1 month, and to 2948±95 at 3 months. In RCMV-infected allografts, the intensity of IGF-1 mRNA expression in the allograft vascular wall followed the same pattern seen in noninfected allografts (Fig 4a) .
EGF. The level of EGF mRNA in nontransplanted DA aortas was 1759 ±635. In noninfected allografts, the intensity of EGF mRNA expression declined to 338±176 at 7 days and to 121 ±42 at 1 month, but increased to 535 ±178 at 3 months. Compared with noninfected allografts, the expression of EGF mRNA in RCMV-infected allografts was significantly upregulated at 1 month to 551±112 (P<.05). Note, however, that EGF mRNA expression in both groups was below the level of nontransplanted DA aortas during the whole experiment (Fig 4b) .
PDGF-BB.
The level of PDGF-BB mRNA in nontransplanted DA aortas was 634±46. In noninfected allografts, PDGF-BB mRNA expression was increased when compared with nontransplanted aortas, reaching 1478±217 at 7 days, 1366±522 at 1 month, and 2480 ±435 at 3 months. RCMV infection induced a significant upregulation in PDGF-BB mRNA expression to 3170±378 at 7 days (P<.05) and to 3276±381 at 1 month (/ > <.O25), when compared with noninfected allografts. Thereafter, the response declined (Fig 4c, 5a) .
TGF-p,. The level of TGF-0, mRNA in nontransplanted DA aortas was 270 ±30. In noninfected allografts, the expression of TGF-0, was 955 ±343 at 7 days, 615 ±107 at 1 month, and reached a peak of 2299 ±687 at 3 months. RCMV infection significantly enhanced TGF-/3, mRNA expression to 4556±461 at 7 days (P<.025) and to 2307±131 at 1 month (i><.025), when compared with noninfected allografts but declined to 50% of that observed in noninfected allografts at 3 months (Fig 4d, 5b) .
aFGF. The intensity of aFGF mRNA expression in nontransplanted DA aortas was 1883 ±297. In noninfected allografts, aFGF mRNA expression declined to 259±31 at 7 days and to 581±158 at 1 month but peaked to 2734±800 at 3 months. RCMV infection significantly elevated (P<.025) aFGF mRNA expression in the allograft vascular wall both at 7 days and at 1 month, when compared with noninfected allografts (Fig 4e) . Note, however, that aFGF mRNA expression in both groups was below the levels of nontransplanted DA aortas at 7 days and 1 month.
bFGF. The expression of bFGF mRNA was 473±45 in nontransplanted DA aortas. In noninfected allografts, the intensity of bFGF mRNA increased to 751 + 280 at 7 days, to 756±210 at 1 month, and to 1283 ±487 at 3 months. RCMV infection almost dou- infection on growth factor mRNA transcription in the vascular wall of aortic allografts. The mRNA expression was semiquantifled by reverse transcriptasepolymerase chain reaction (RT-PCR) at 7 days (n=6), at 1 month (n=6), and at 3 months (n=3) after transplantation. The conesponding numbers in noninfected allografts were 7, 3, and 3. Total RNA was extracted from aortic transplants with guanidine-isothlocyanate preparations. RNA was transcripted to cDNA using commercial Perkin Elmer Cetus Protocol. Complementary DNA was taken for PCR, and the samples were amplified 25 to 28 cycles each. As controls, PCR was also made using glyceraldehyde 3-phosphate dehydrogenase (GAPDH) primers. The samples were electrophoresed In agarose gel and Southern-blotted. Radlolabeled oligo probes were used to detect PCR products, and the intensity of hybridization signals was measured by densitometry. The responses are given as the ratio of growth factor mRNA to GAPDH mRNA, and values represent mean±SEM. Framed area indicates growth factor mRNA expression in nontransplanted DA aortas (mean±SD). The test was repeated at least three times, and the results presented here are derived from the last experiment Significances by MannWhitney a test; *P<.05, **P<.025.
bled the bFGF mRNA expression in the allograft vascular wall to 1547±262 at 7 days and to 1342±215 at 1 month, but the difference was not statistically significant. At 3 months, the bFGF mRNA expression was similar to noninfected allografts (Fig 4f) .
Discussion
Cardiac allogTaft arteriosclerosis is a major obstacle in long-term survival after heart transplantation. 1 46 Our recent studies show that RCMV infection enhances inflammatory cell proliferation in the allograft adventitia (perivasculitis) and induces a T helper cell-and monocyte/macrophage-containing subendothelial inflammation (endothelialitis) beneath the endothelium. 8 Concomitantly with the inflammatory response, RCMV infection doubles SMC proliferation and intimal thickening of rat aortic allografts. adventitia. Second, these cells displayed enhanced levels of immune activation, ie, the expression of MHC class II, and possibly IL-2 receptor, ICAM-1, and LFA-1 a-chain. Third, and most notably, RCMV infection was linked with an early, prominent PDGF-BB and TGF-ft mRNA expression in the allograft vascular wall. The expression of other growth factors (EGF, aFGF, bFGF) was also elevated, but the differences were not statistically significant, and/or the level of response was below nontransplanted controls.
Allograft arteriosclerosis is generally considered to result from the proliferation and migration of SMCs from the media into the intima, in association with increased deposits of extracellular matrix material and lipids. Our current results suggest some pathways whereby the process is regulated in RCMV-enhanced allograft arteriosclerosis.
So far we have not been able to demonstrate any trace of RCMV in the allograft. Only occasionally have some inflammatory cells and some endothelial cells of the allografts been positive in immunostaining for early and late antigens of RCMV (unpublished results). Thus, the regulation by intact virus is unlikely. Another possible explanation is that viral infection transforms cells by incorporating into the cell genome. This is also unlikely, as we have been unable to demonstrate any viral genome in the proliferating cells by in situ hybridization (unpublished results). In other words, we have not been able to provide any evidence for a direct regulatory effect of RCMV on allograft arteriosclerosis.
On the other hand, we have demonstrated that RCMV infection enhances the early inflammatory response and the activation level of inflammatory cells in the allograft adventitia and may thus have an indirect impact on SMC proliferation via acute and/or chronic inflammation. Immune activation in RCMV-infected allografts and the enhancement of peptide growth factor mRNA expression, coincided with the accelerated and enhanced SMC proliferative response seen in RCMV-infected allografts. Thus, we consider that the RCMV-enhanced intimal changes may reflect the elevated inflammatory and immunologic responses, linked with upregulated transcription of SMC mitogens, especially of PDGF-BB and TGF-ft.
Several other studies also suggest the pro-inflammation role of CMV infection. Evidence exists that human CMV infection upregulates IL-1/3 gene expression, leading to increased production of IL-1 by monocyte/ macrophages and to enhancement of inflammatory responses. 26 Studies in AIDS patients with CMV-induced severe colitis have shown that CMV induces the production of TNF-a by monocytes and mucosal macrophages. 27 The immediate early gene of human CMV is able to code for a protein that has sequence homology and immunologic cross-reactivity with HLA-DR 0-chain. 28 In addition, human CMV encodes a grycoprotein that is homologous to MHC class I antigens. 29 In vitro studies have demonstrated that the immediate early genes of human CMV upregulate the expression of IL-2 and IL-2-receptor genes. 30 These observations are in accordance with our observations and with our interpretation.
How do the likely effector molecules, the growth factors, operate in the atherosclerotic process? PDGF is a potent SMC chemoattractant and mitogen. 31 - 32 It is present in platelets and can be produced by endothelium, SMCs, macrophages, 31 and a large number of cells transformed by DNA or retroviruses. 33 - 34 Observations on subcultured rat aortic SMCs have demonstrated that PDGF-BB is the most potent growth factor for SMCs, followed by FGF, EGF, and to lesser extent by PDGF-AA, IGF-1, and TGF-/3. 35 Furthermore, recent experiments strongly suggest that SMC migration is a key step for the growth of intimal lesions and is possibly mediated by PDGF. 3638 Increased expression of PDGF-/3 receptor in the media of arteries and in a number of myocardial cells in association with T cells and monocyte/macrophage infiltration has been observed in rat cardiac allografts. 39 Transforming growth factors were first identified as products of virus-transformed cells. 40 TGF-/3] is present in a-granules of platelets 41 and is secreted by monocyte/ macrophages, activated T cells, endothelial cells, and SMCs. 42 TGF-/3i is secreted in vivo in inactive form, and the target specificity of TGF-yS, action may be determined by the ability of a cell to activate the latent complex. 42 TGF-0 controls the production of extracellular matrix proteins and inhibits the degradation of newly formed matrix proteins and may thus contribute to the development of fibroproliferative disorder. 4345 Furthermore, a recent study using rat cardiac allografts shows that TGF-/3 bioactivity dramatically increases in the transplanted allografts during chronic rejection. 46 TGF-/3 is also a potent inhibitor of the proliferation of many cell types in vitro. 42 TGF-/3 inhibits the proliferative response of quiescent SMCs exposed to serum or EGF; however, when the same cells are grown in soft agar in 10% serum, TGF-/3, combined with EGF or PDGF, stimulates SMC proliferation. 41 TGF-0, stimulates the growth of certain fibroblasts in vitro in the presence of PDGF but inhibits it if EGF is present. 47 Furthermore, evidence exists showing that TGF-/3 is able to modulate immune responses and inflammation, augmenting certain immune responses while suppressing others. 4344 Most of the cell types involved in allograft arteriosclerosis are capable of expressing IGF-1, IGF-1 receptors, and IGF-binding proteins, or combinations of these proteins, but IGF-1 alone appears in most cases to be only a weak mitogen for vascular SMCs. 48 Autocrine or paracrine production of IGF-1 is believed to be necessary for PDGF to exert its mitogenic effects on SMCs and fibroblasts in vitro. 49 Several studies strongly suggest that bFGF may be a key mitogen for the initiation of SMC replication after vascular injury but is not important for the continuation of intimal SMC replication. 5052 A recent study in human cardiac allografts using quantitative PCR and intracoronary ultrasound suggests a trend toward a correlation between the quantity of aFGF mRNA present in the allograft myocardium and the degree of coronary intimal thickening. 53 Principal growth regulatory molecules participating in the development of arteriosclerotic lesions, both in ordinary coronary artery disease and in transplantation-associated arteriosclerosis, include PDGF, TGF-/3, and IGF-1. 34 - 54 Our studies with rat aortic allografts demonstrate that during chronic rejection, in the absence of RCMV infection, the messages of IGF-1, PDGF-BB, and TGF-/3, are prominently expressed at 3 months after transplantation. 910 RCMV infection in the allograft recipients induces an early, enhanced inflammatory response both in the adventitia and intima, ie, perivasculitis and endothelialitis, which is followed by enhanced SMC replication and enhanced intimal thickening 7 -8 as well as by concomitant upregulation of PDGF-BB and TGF-yS, mRNA. Thus, the present study suggests that these growth factors may be responsible for the RCMV-enhanced proliferative response and intimal thickening by increasing the migration of SMCs into the subendothelial space 37 and their proliferation there. In addition, TGF-/3, may enhance extracellular matrix formation as well as modulate inflammatory responses. 4345 
